Ron Eastman is a Managing Director at EW Healthcare Partners (formerly
Essex Woodlands) in Palo Alto, CA. Having over 35 years of experience in
building healthcare businesses, Ron began his career at American Cyanamid
Company. There he managed pharmaceutical products, divisions and subsidiaries
in the U.S. and overseas, and has since helped build three private healthcare
companies—Geron, HCORP, and Rinat Neuroscience.
Under his leadership, Geron became a cutting-edge biotech company
growing from a venture-backed startup to a publicly traded pioneer in
regenerative medicine and cancer treatment. HCORP established itself as the
leader in hospital-based, interactive patient services, and was sold to a
diversified competitor. At Rinat, Ron led the effort to build the first company
dedicated to discovering and developing large molecule drugs for treating
nervous system disorders. Rinat was acquired by Pfizer for $500 million in
Mr. Eastman serves on the boards of Corium International, EluSys
Therapeutics, Inc. and IntegenX Inc.